Immunocore Holdings (IMCR) Return on Equity [ROE] (2022 - 2026)
Immunocore Holdings' Return on Equity [ROE] was -4.45% in Q2 2026, up 0.86 percentage points from -5.31% a year earlier and up 2.67 percentage points from the prior quarter.
Immunocore Holdings (IMCR) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Immunocore Holdings came in at -9.58%, up 4.43 percentage points from FY2024.
- Return on Equity [ROE] has now increased for six consecutive years, with a five-year change of +202.94 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -14.00% in FY2024 (+1.62 pp), -15.62% in FY2023 (+1.27 pp), -16.89% in FY2022 (+101.08 pp) and -117.97% in FY2021 (+94.55 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to Q3 2022.
- Compared with a year earlier, Return on Equity [ROE] was higher in seven of the last eight quarters, with an average year-over-year change of +5.07 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2023 (a gain of 19.28 percentage points); the worst was Q1 2026 (a drop of 1.26 percentage points).
- Per Business Quant data, IMCR's Return on Equity [ROE] in the three quarters before Q2 2026 was -7.12% (Q1 2026), -9.15% (Q4 2025) and -7.46% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Immunocore Holdings | 1.53 Bn | -1.95 Bn | 114.84 Mn | -4.45% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.45% |
| Mar 31, 2026 | -7.12% |
| Dec 31, 2025 | -9.15% |
| Sep 30, 2025 | -7.46% |
| Jun 30, 2025 | -5.31% |
| Mar 31, 2025 | -5.87% |
| Dec 31, 2024 | -13.85% |
| Sep 30, 2024 | -12.78% |
| Jun 30, 2024 | -15.29% |
| Mar 31, 2024 | -17.63% |
| Dec 31, 2023 | -16.33% |
| Sep 30, 2023 | -19.51% |
| Jun 30, 2023 | -18.06% |
| Mar 31, 2023 | -18.55% |
| Dec 31, 2022 | -28.36% |
| Sep 30, 2022 | -38.79% |
Immunocore Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();